Diadenosine polyphosphates are selective vasoconstrictors in human coronary artery bypass grafts

Vascular Pharmacology

Volumn 48, Issue 4-6, 2008, Pages 157-164

  Conant, Alan R ^a   Theologou, Thomas ^a   Dihmis, Walid C ^a   Simpson, Alec W M ^b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Coronary artery bypass graft; Diadenosine polyphosphate; Human; P2X receptor; Vasoconstriction

Indexed keywords

8,8' [CARBONYL BIS(IMINO 4,1 PHENYLENECARBONYLIMINO 4,1 PHENYLENECARBONYLIMINO)]BIS 1,3,5 NAPHTHALENETRISULFONIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA BETA METHYLENE ADENOSINE TRIPHOSPHATE; DIADENOSINE HEXAPHOSPHATE; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE POLYPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR BLOCKING AGENT; SURAMIN;

ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DESENSITIZATION; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MAMMARY ARTERY; PRIORITY JOURNAL; RADIAL ARTERY; SAPHENOUS VEIN; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; CORONARY ARTERY BYPASS; DINUCLEOSIDE PHOSPHATES; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; PYRIDOXAL PHOSPHATE; RADIAL ARTERY; RECEPTORS, PURINERGIC P1; SAPHENOUS VEIN; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 43649106045     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.01.005     Document Type: Article

References (46)

1. Acar C., Jebara V.A., Portoghese M., Fontaliran F., Dervanian P., Chachques J.C., Meininger V., and Carpentier A. Comparative anatomy and histology of the radial artery and the internal thoracic artery - implication for coronary-artery bypass. Surg. Radiol. Anat. 13 (1991) 283-288
2. Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C., Alexander K.M., Park H.S., Yu H.X., Metzger R., Kowaluk E., Jarvis M.F., and van Biesen T. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376 (1999) 127-138
3. Bo X.N., Sexton A., Xiang Z.H., Nori S.L., and Burnstock G. Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. Eur. J. Pharmacol. 353 (1998) 59-65
4. Borland J.A.A., Chester A.H., Rooker S.J., Wharton J., Davie N., Amrani M., and Yacoub M.H. Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery. Ann. Thorac. Surg. 70 (2000) 2054-2063
5. Borna C., Wang L.W., Gudbjartsson T., Karlsson L., Jern S., Malmsjo M., and Erlinge D. Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann. Thorac. Surg. 76 (2003) 50-57
6. Cable D.G., Caccitolo J.A., Pearson P.J., OBrien T., Mullany C.J., Daly R.C., Orszulak T.A., and Schaff H.V. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation 98 (1998) II15-II21
7. Chanda J., Brichkov I., and Canver C.C. Prevention of radial artery graft vasospasm after coronary bypass. Ann. Thorac. Surg. 70 (2000) 2070-2074
8. Chardigny C., Jebara V.A., Acar C., Descombes J.J., Verbeuren T.J., Carpentier A., and Fabiani J.N. Vasoreactivity of the radial artery - comparison with the internal mammary and gastroepiploic arteries with implications for coronary-artery surgery. Circulation 88 (1993) 115-127
9. Chen B.C., Lee C.M., and Lin W.W. Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C-6 glioma cells and RAW 264.7 macrophages. Br. J. Pharmacol. 119 (1996) 1628-1634
10. Chester A.H., Marchbank A.J., Borland J.A., Yacoub M.H., and Taggart D.P. Comparison of the morphologic and vascular reactivity of the proximal and distal radial artery. Ann. Thorac. Surg. 66 (1998) 1972-1976
11. Conant A.R., Fisher M.J., McLennan A.G., and Simpson A.M. Characterization of the P2 receptors on the human umbilical vein endothelial cell line ECV304. Br. J. Pharmacol. 125 (1998) 357-364
12. Crack B.E., Beukers M.W., Mckechnie K.C.W., Ijzerman A.P., and Leff P. Pharmacological analysis of ecto-atpase inhibition - evidence for combined enzyme-inhibition and receptor antagonism in P-2X-purinoceptor ligands. Br. J. Pharmacol. 113 (1994) 1432-1438
13. Davies G., MacAllister R.J., Bogle R.G., and Vallance P. Effect of diadenosine phosphates on human umbilical vessels - novel platelet-derived vasoconstrictors. Br. J. Clin. Pharmacol. 40 (1995) 170-172
14. Flodgaard H., and Klenow H. Abundant amounts of diadenosine 5′5‴-P1,P4-tetraphosphate are present and releasable but metabolically inactive, in human-platelets. Biochem. J. 208 (1982) 737-742
15. Flores N.A., Stavrou B.M., and Sheridan D.J. The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc. Res. 42 (1999) 15-26
16. nA). Cardiovasc. Res. 56 (2002) 22-32
17. He G.W., Angus J.A., and Rosenfeldt F.L. Reactivity of the canine isolated internal mammary artery, saphenous-vein, and coronary-artery to constrictor and dilator substances - relevance to coronary-bypass graft-surgery. J. Cardiovasc. Pharmacol. 12 (1988) 12-22
18. He G.W., Rosenfeldt F.L., and Angus J.A. Pharmacological relaxation of the saphenous-vein during harvesting for coronary-artery bypass-grafting. Ann. Thorac. Surg. 55 (1993) 1210-1217
19. He G.W., and Yang C.Q. Comparison among arterial grafts and coronary-artery - an attempt at functional classification. J. Thorac. Cardiovasc. Surg. 109 (1995) 707-715
20. He G.W., and Yang C.Q. Radial artery has higher receptor-mediated contractility but similar endothelial function compared with mammary artery. Ann. Thorac. Surg. 63 (1997) 1346-1352
21. He G.W., and Yang C.Q. Characteristics of adrenoceptors in the human radial artery: clinical implications. J. Thorac. Cardiovasc. Surg. 115 (1998) 1136-1141
22. Jankowski J., Hagemann J., Tepel M., van der Giet M., Stephan N., Henning L., Gouni-Berthold I., Sachinidis A., Zidek W., and Schluter H. Dinucleotides as growth-promoting extracellular mediators - presence of dinucleoside diphosphates Ap(2)A, Ap(2)G, and Gp(2)G in releasable granules of platelets. J. Biol. Chem. 276 (2001) 8904-8909
23. Jankowski J., Potthoff W., van der Giet M., Tepel M., Zidek W., and Schluter H. High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets. Anal. Biochem. 269 (1999) 72-78
24. Kikuta Y., Ohiwa E., Okada K., Watanabe A., and Haruki S. Clinical application of diadenosine tetraphosphate (Ap(4)A:F-1500) for controlled hypotension. Acta. Anaesthesiol. Scand. 43 (1999) 82-86
25. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn-Schmied. Arch. Pharmacol. 362 (2000) 340-350
26. Lewis C.J., and Evans R.J. P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J. Vasc. Res. 38 (2001) 332-340
27. Loop F.D., Lytle B.W., Cosgrove D.M., Stewart R.W., Goormastic M., Williams G.W., Golding L.A.R., Gill C.C., Taylor P.C., Sheldon W.C., and Proudfit W.L. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N. Engl. J. Med. 314 (1986) 1-6
28. Lytle B.W. Prolonging patency - choosing coronary bypass grafts. N. Engl. J. Med. 351 (2004) 2262-2264
29. Metcalfe M.J., Baker D.D., Turmaine M., and Burnstock G. Alterations in purinoceptor expression in human long saphenous vein during varicose disease. Eur. J. Vasc. Endovasc. Surg. 33 (2007) 239-250
30. Nicke A., Kerschensteiner D., and Soto F. Biochemical and functional evidence for heteromeric assembly of P2X(1) and P2X(4) subunits. J. Neurochem. 92 (2005) 925-933
31. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
32. nA. In: McLennan A.G. (Ed). Ap4A and Other Dinucleoside Polyphosphates (1992), CRC Press Inc, Boca Raton, FI 229-273
33. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
34. Rettinger J., Schmalzing G., Damer S., Muller G., Nickel P., and Lambrecht G. The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor. Neuropharmacology 39 (2000) 2044-2053
35. Rosenfeldt F.L., He G.W., Buxton B.F., and Angus J.A. Pharmacology of coronary artery bypass grafts. Ann. Thorac. Surg. 67 (1999) 878-888
36. Schluter H., Offers E., Bruggemann G., vanderGiet M., Tepel M., Nordhoff E., Karas M., Spieker C., Witzel H., and Zidek W. Diadenosine phosphates and the physiological control of blood-pressure. Nature 367 (1994) 186-188
37. Stahli B.E., Greutert H., Mei S.P., Graf P., Frischknecht K., Stalder M., Englberger L., Kunzli A.K., Scharer L., Luscher T.F., Carrel T.P., and Tanner F.C. Absence of histamine-induced nitric oxide release in the human radial artery: implications for vasospasm of coronary artery bypass vessels. Am. J. Physiol. 290 (2006) H1182-H1189
38. Steinmetz M., Gabriels G., Van Le T., Piechota H.J., Rahn K.H., and Schlatter E. Vasoactivity of diadenosine polyphosphates in human small renal resistance arteries. Nephrol. Dial. Transplantation. 18 (2003) 2496-2504
39. Steinmetz M., Janssen A.K., Pelster F., Rahn K.H., and Schlatter E. Vasoactivity of diadenosine polyphosphates in human small mesenteric resistance arteries. J. Pharmacol. Exp. Ther. 302 (2002) 787-794
40. van Ginneken E.E.M., Rongen G.A., Russel F.G.M., and Smits P. Diadenosine pentaphosphate vasodilates the forearm vascular bed: inhibition by theophylline and augmentation by dipyridamole. Clin. Pharmacol. Ther. 71 (2002) 448-456
41. van Son J.A.M., Smedts F., Vincent J.G., Vanlier H.J.J., and Kubat K. Comparative anatomic studies of various arterial conduits for myocardial revascularization. J. Thorac. Cardiovasc. Surg. 99 (1990) 703-707
42. von Kugelgen I., Krumme B., Schaible U., Schollmeyer P.J., and Rump L.C. Vasoconstrictor responses to the P-2X-purinoceptor agonist beta,gamma-methylene-l-ATP in human cutaneous and renal blood-vessels. Br. J. Pharmacol. 116 (1995) 1932-1936
43. Wang L.W., Karlsson L., Moses S., Hultgardh-Nilsson A., Andersson M., Borna C., Gudbjartsson T., Jern S., and Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol. 40 (2002) 841-853
44. Wei W., Yang C.Q., Furnary A., and He G.W. Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery. J. Thorac. Cardiovasc. Surg. 129 (2005) 33-40
45. Ziganshin A.U., Ziganshin B.A., Giniyatova L.R., and Dzhordzhikiya R.K. Effect of PPADS on P2X receptor-mediated responses of human blood vessels. Bull. Exp. Biol. Med. 137 (2004) 284-287
46. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmied. Arch. Pharmacol. 362 (2000) 299-309